Sudden death during adjuvant trastuzumab therapy of breast cancer

Annals of Oncology

Volumn 21, Issue 4, 2009, Pages 901-

  Oliveira, M ^a   Nave, M ^b   Gil, N ^b   Passos Coelho, J L ^a,b  

^a Medical Oncology Service   (Portugal)

^b HOSPITAL DA LUZ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PERINDOPRIL; TAMOXIFEN; TRASTUZUMAB;

ADULT; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CASE REPORT; DEPRESSION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HOLTER MONITORING; HUMAN; INTRADUCTAL CARCINOMA; LETTER; LUNG CONGESTION; LYMPHOCYTIC INFILTRATION; MITRAL VALVE PROLAPSE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; SUDDEN DEATH; SUPRAVENTRICULAR PREMATURE BEAT; SYSTOLE;

EID: 77951957754     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp587     Document Type: Letter

References (4)

1. Seidman A, Hudis C, Pierri MK et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002; 20: 1215-1221.
2. Perez EA, Rodeheffer R. Clinical cardiac tolerability of trastuzumab. J Clin Oncol 2004; 22: 322-329.
3. Olin RL, Desai SS, Fox K et al. Non-myopathic cardiac events in two patients treated with trastuzumab. Breast J 2007; 13: 211-212.
4. Ferguson C, Clarke J, Herity NA. Ventricular tachycardia associated with trastuzumab. N Engl J Med 2006; 354: 648-649.